Global Non-Animal Softgel Capsules Market Analysis and Forecast 2024-2030

Global Non-Animal Softgel Capsules Market Analysis and Forecast 2024-2030


Summary

According to APO Research, The global Non-Animal Softgel Capsules market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Non-Animal Softgel Capsules is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

Asia-Pacific market for Non-Animal Softgel Capsules is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

The China market for Non-Animal Softgel Capsules is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

Europe market for Non-Animal Softgel Capsules is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

The major global manufacturers of Non-Animal Softgel Capsules include Catalent, Procaps Laboratorios, EuroCaps, Best Formulations, Aenova, Captek, Sirio, Bahrain Pharma and Robinson Pharma, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Non-Animal Softgel Capsules, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.

This report researches the key producers of Non-Animal Softgel Capsules, also provides the sales of main regions and countries. Of the upcoming market potential for Non-Animal Softgel Capsules, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Non-Animal Softgel Capsules sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Non-Animal Softgel Capsules market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Non-Animal Softgel Capsules sales, projected growth trends, production technology, application and end-user industry.

Non-Animal Softgel Capsules segment by Company

Catalent
Procaps Laboratorios
EuroCaps
Best Formulations
Aenova
Captek
Sirio
Bahrain Pharma
Robinson Pharma
Aland
Fuji Capsule
Sunsho Pharmaceutical
Erkang
Non-Animal Softgel Capsules segment by Type

Plant Polysaccharides Softgel Capsules
Starch Softgel Capsules
Non-Animal Softgel Capsules segment by Application

Health Supplements
Pharmaceutical
Others
Non-Animal Softgel Capsules segment by Region

North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Non-Animal Softgel Capsules market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Non-Animal Softgel Capsules and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Non-Animal Softgel Capsules.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Sales (consumption), revenue of Non-Animal Softgel Capsules in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 4: Detailed analysis of Non-Animal Softgel Capsules manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Non-Animal Softgel Capsules sales, revenue, price, gross margin, and recent development, etc.
Chapter 8: North America (US & Canada) by type, by application and by country, sales, and revenue for each segment.
Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.
Chapter 10: China type, by application, sales, and revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.
Chapter 12: Middle East, Africa, and Latin America type, by application and by country, sales, and revenue for each segment.
Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 14: The main concluding insights of the report.


1 Market Overview
1.1 Product Definition
1.2 Non-Animal Softgel Capsules Market by Type
1.2.1 Global Non-Animal Softgel Capsules Market Size by Type, 2019 VS 2023 VS 2030
1.2.2 Plant Polysaccharides Softgel Capsules
1.2.3 Starch Softgel Capsules
1.3 Non-Animal Softgel Capsules Market by Application
1.3.1 Global Non-Animal Softgel Capsules Market Size by Application, 2019 VS 2023 VS 2030
1.3.2 Health Supplements
1.3.3 Pharmaceutical
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Goals and Objectives
2 Non-Animal Softgel Capsules Market Dynamics
2.1 Non-Animal Softgel Capsules Industry Trends
2.2 Non-Animal Softgel Capsules Industry Drivers
2.3 Non-Animal Softgel Capsules Industry Opportunities and Challenges
2.4 Non-Animal Softgel Capsules Industry Restraints
3 Global Market Growth Prospects
3.1 Global Non-Animal Softgel Capsules Revenue Estimates and Forecasts (2019-2030)
3.2 Global Non-Animal Softgel Capsules Revenue by Region
3.2.1 Global Non-Animal Softgel Capsules Revenue by Region: 2019 VS 2023 VS 2030
3.2.2 Global Non-Animal Softgel Capsules Revenue by Region (2019-2024)
3.2.3 Global Non-Animal Softgel Capsules Revenue by Region (2025-2030)
3.2.4 Global Non-Animal Softgel Capsules Revenue Market Share by Region (2019-2030)
3.3 Global Non-Animal Softgel Capsules Sales Estimates and Forecasts 2019-2030
3.4 Global Non-Animal Softgel Capsules Sales by Region
3.4.1 Global Non-Animal Softgel Capsules Sales by Region: 2019 VS 2023 VS 2030
3.4.2 Global Non-Animal Softgel Capsules Sales by Region (2019-2024)
3.4.3 Global Non-Animal Softgel Capsules Sales by Region (2025-2030)
3.4.4 Global Non-Animal Softgel Capsules Sales Market Share by Region (2019-2030)
3.5 US & Canada
3.6 Europe
3.7 China
3.8 Asia (Excluding China)
3.9 Middle East, Africa and Latin America
4 Market Competitive Landscape by Manufacturers
4.1 Global Non-Animal Softgel Capsules Revenue by Manufacturers
4.1.1 Global Non-Animal Softgel Capsules Revenue by Manufacturers (2019-2024)
4.1.2 Global Non-Animal Softgel Capsules Revenue Market Share by Manufacturers (2019-2024)
4.1.3 Global Non-Animal Softgel Capsules Manufacturers Revenue Share Top 10 and Top 5 in 2023
4.2 Global Non-Animal Softgel Capsules Sales by Manufacturers
4.2.1 Global Non-Animal Softgel Capsules Sales by Manufacturers (2019-2024)
4.2.2 Global Non-Animal Softgel Capsules Sales Market Share by Manufacturers (2019-2024)
4.2.3 Global Non-Animal Softgel Capsules Manufacturers Sales Share Top 10 and Top 5 in 2023
4.3 Global Non-Animal Softgel Capsules Sales Price by Manufacturers (2019-2024)
4.4 Global Non-Animal Softgel Capsules Key Manufacturers Ranking, 2022 VS 2023 VS 2024
4.5 Global Non-Animal Softgel Capsules Key Manufacturers Manufacturing Sites & Headquarters
4.6 Global Non-Animal Softgel Capsules Manufacturers, Product Type & Application
4.7 Global Non-Animal Softgel Capsules Manufacturers Commercialization Time
4.8 Market Competitive Analysis
4.8.1 Global Non-Animal Softgel Capsules Market CR5 and HHI
4.8.2 2023 Non-Animal Softgel Capsules Tier 1, Tier 2, and Tier 3
5 Non-Animal Softgel Capsules Market by Type
5.1 Global Non-Animal Softgel Capsules Revenue by Type
5.1.1 Global Non-Animal Softgel Capsules Revenue by Type (2019 VS 2023 VS 2030)
5.1.2 Global Non-Animal Softgel Capsules Revenue by Type (2019-2030) & (US$ Million)
5.1.3 Global Non-Animal Softgel Capsules Revenue Market Share by Type (2019-2030)
5.2 Global Non-Animal Softgel Capsules Sales by Type
5.2.1 Global Non-Animal Softgel Capsules Sales by Type (2019 VS 2023 VS 2030)
5.2.2 Global Non-Animal Softgel Capsules Sales by Type (2019-2030) & (M Capsules)
5.2.3 Global Non-Animal Softgel Capsules Sales Market Share by Type (2019-2030)
5.3 Global Non-Animal Softgel Capsules Price by Type
6 Non-Animal Softgel Capsules Market by Application
6.1 Global Non-Animal Softgel Capsules Revenue by Application
6.1.1 Global Non-Animal Softgel Capsules Revenue by Application (2019 VS 2023 VS 2030)
6.1.2 Global Non-Animal Softgel Capsules Revenue by Application (2019-2030) & (US$ Million)
6.1.3 Global Non-Animal Softgel Capsules Revenue Market Share by Application (2019-2030)
6.2 Global Non-Animal Softgel Capsules Sales by Application
6.2.1 Global Non-Animal Softgel Capsules Sales by Application (2019 VS 2023 VS 2030)
6.2.2 Global Non-Animal Softgel Capsules Sales by Application (2019-2030) & (M Capsules)
6.2.3 Global Non-Animal Softgel Capsules Sales Market Share by Application (2019-2030)
6.3 Global Non-Animal Softgel Capsules Price by Application
7 Company Profiles
7.1 Catalent
7.1.1 Catalent Comapny Information
7.1.2 Catalent Business Overview
7.1.3 Catalent Non-Animal Softgel Capsules Sales, Revenue, Price and Gross Margin (2019-2024)
7.1.4 Catalent Non-Animal Softgel Capsules Product Portfolio
7.1.5 Catalent Recent Developments
7.2 Procaps Laboratorios
7.2.1 Procaps Laboratorios Comapny Information
7.2.2 Procaps Laboratorios Business Overview
7.2.3 Procaps Laboratorios Non-Animal Softgel Capsules Sales, Revenue, Price and Gross Margin (2019-2024)
7.2.4 Procaps Laboratorios Non-Animal Softgel Capsules Product Portfolio
7.2.5 Procaps Laboratorios Recent Developments
7.3 EuroCaps
7.3.1 EuroCaps Comapny Information
7.3.2 EuroCaps Business Overview
7.3.3 EuroCaps Non-Animal Softgel Capsules Sales, Revenue, Price and Gross Margin (2019-2024)
7.3.4 EuroCaps Non-Animal Softgel Capsules Product Portfolio
7.3.5 EuroCaps Recent Developments
7.4 Best Formulations
7.4.1 Best Formulations Comapny Information
7.4.2 Best Formulations Business Overview
7.4.3 Best Formulations Non-Animal Softgel Capsules Sales, Revenue, Price and Gross Margin (2019-2024)
7.4.4 Best Formulations Non-Animal Softgel Capsules Product Portfolio
7.4.5 Best Formulations Recent Developments
7.5 Aenova
7.5.1 Aenova Comapny Information
7.5.2 Aenova Business Overview
7.5.3 Aenova Non-Animal Softgel Capsules Sales, Revenue, Price and Gross Margin (2019-2024)
7.5.4 Aenova Non-Animal Softgel Capsules Product Portfolio
7.5.5 Aenova Recent Developments
7.6 Captek
7.6.1 Captek Comapny Information
7.6.2 Captek Business Overview
7.6.3 Captek Non-Animal Softgel Capsules Sales, Revenue, Price and Gross Margin (2019-2024)
7.6.4 Captek Non-Animal Softgel Capsules Product Portfolio
7.6.5 Captek Recent Developments
7.7 Sirio
7.7.1 Sirio Comapny Information
7.7.2 Sirio Business Overview
7.7.3 Sirio Non-Animal Softgel Capsules Sales, Revenue, Price and Gross Margin (2019-2024)
7.7.4 Sirio Non-Animal Softgel Capsules Product Portfolio
7.7.5 Sirio Recent Developments
7.8 Bahrain Pharma
7.8.1 Bahrain Pharma Comapny Information
7.8.2 Bahrain Pharma Business Overview
7.8.3 Bahrain Pharma Non-Animal Softgel Capsules Sales, Revenue, Price and Gross Margin (2019-2024)
7.8.4 Bahrain Pharma Non-Animal Softgel Capsules Product Portfolio
7.8.5 Bahrain Pharma Recent Developments
7.9 Robinson Pharma
7.9.1 Robinson Pharma Comapny Information
7.9.2 Robinson Pharma Business Overview
7.9.3 Robinson Pharma Non-Animal Softgel Capsules Sales, Revenue, Price and Gross Margin (2019-2024)
7.9.4 Robinson Pharma Non-Animal Softgel Capsules Product Portfolio
7.9.5 Robinson Pharma Recent Developments
7.10 Aland
7.10.1 Aland Comapny Information
7.10.2 Aland Business Overview
7.10.3 Aland Non-Animal Softgel Capsules Sales, Revenue, Price and Gross Margin (2019-2024)
7.10.4 Aland Non-Animal Softgel Capsules Product Portfolio
7.10.5 Aland Recent Developments
7.11 Fuji Capsule
7.11.1 Fuji Capsule Comapny Information
7.11.2 Fuji Capsule Business Overview
7.11.3 Fuji Capsule Non-Animal Softgel Capsules Sales, Revenue, Price and Gross Margin (2019-2024)
7.11.4 Fuji Capsule Non-Animal Softgel Capsules Product Portfolio
7.11.5 Fuji Capsule Recent Developments
7.12 Sunsho Pharmaceutical
7.12.1 Sunsho Pharmaceutical Comapny Information
7.12.2 Sunsho Pharmaceutical Business Overview
7.12.3 Sunsho Pharmaceutical Non-Animal Softgel Capsules Sales, Revenue, Price and Gross Margin (2019-2024)
7.12.4 Sunsho Pharmaceutical Non-Animal Softgel Capsules Product Portfolio
7.12.5 Sunsho Pharmaceutical Recent Developments
7.13 Erkang
7.13.1 Erkang Comapny Information
7.13.2 Erkang Business Overview
7.13.3 Erkang Non-Animal Softgel Capsules Sales, Revenue, Price and Gross Margin (2019-2024)
7.13.4 Erkang Non-Animal Softgel Capsules Product Portfolio
7.13.5 Erkang Recent Developments
8 North America
8.1 North America Non-Animal Softgel Capsules Market Size by Type
8.1.1 North America Non-Animal Softgel Capsules Revenue by Type (2019-2030)
8.1.2 North America Non-Animal Softgel Capsules Sales by Type (2019-2030)
8.1.3 North America Non-Animal Softgel Capsules Price by Type (2019-2030)
8.2 North America Non-Animal Softgel Capsules Market Size by Application
8.2.1 North America Non-Animal Softgel Capsules Revenue by Application (2019-2030)
8.2.2 North America Non-Animal Softgel Capsules Sales by Application (2019-2030)
8.2.3 North America Non-Animal Softgel Capsules Price by Application (2019-2030)
8.3 North America Non-Animal Softgel Capsules Market Size by Country
8.3.1 North America Non-Animal Softgel Capsules Revenue Grow Rate by Country (2019 VS 2023 VS 2030)
8.3.2 North America Non-Animal Softgel Capsules Sales by Country (2019 VS 2023 VS 2030)
8.3.3 North America Non-Animal Softgel Capsules Price by Country (2019-2030)
8.3.4 United States
8.3.5 Canada
9 Europe
9.1 Europe Non-Animal Softgel Capsules Market Size by Type
9.1.1 Europe Non-Animal Softgel Capsules Revenue by Type (2019-2030)
9.1.2 Europe Non-Animal Softgel Capsules Sales by Type (2019-2030)
9.1.3 Europe Non-Animal Softgel Capsules Price by Type (2019-2030)
9.2 Europe Non-Animal Softgel Capsules Market Size by Application
9.2.1 Europe Non-Animal Softgel Capsules Revenue by Application (2019-2030)
9.2.2 Europe Non-Animal Softgel Capsules Sales by Application (2019-2030)
9.2.3 Europe Non-Animal Softgel Capsules Price by Application (2019-2030)
9.3 Europe Non-Animal Softgel Capsules Market Size by Country
9.3.1 Europe Non-Animal Softgel Capsules Revenue Grow Rate by Country (2019 VS 2023 VS 2030)
9.3.2 Europe Non-Animal Softgel Capsules Sales by Country (2019 VS 2023 VS 2030)
9.3.3 Europe Non-Animal Softgel Capsules Price by Country (2019-2030)
9.3.4 Germany
9.3.5 France
9.3.6 U.K.
9.3.7 Italy
9.3.8 Netherlands
10 China
10.1 China Non-Animal Softgel Capsules Market Size by Type
10.1.1 China Non-Animal Softgel Capsules Revenue by Type (2019-2030)
10.1.2 China Non-Animal Softgel Capsules Sales by Type (2019-2030)
10.1.3 China Non-Animal Softgel Capsules Price by Type (2019-2030)
10.2 China Non-Animal Softgel Capsules Market Size by Application
10.2.1 China Non-Animal Softgel Capsules Revenue by Application (2019-2030)
10.2.2 China Non-Animal Softgel Capsules Sales by Application (2019-2030)
10.2.3 China Non-Animal Softgel Capsules Price by Application (2019-2030)
11 Asia (Excluding China)
11.1 Asia Non-Animal Softgel Capsules Market Size by Type
11.1.1 Asia Non-Animal Softgel Capsules Revenue by Type (2019-2030)
11.1.2 Asia Non-Animal Softgel Capsules Sales by Type (2019-2030)
11.1.3 Asia Non-Animal Softgel Capsules Price by Type (2019-2030)
11.2 Asia Non-Animal Softgel Capsules Market Size by Application
11.2.1 Asia Non-Animal Softgel Capsules Revenue by Application (2019-2030)
11.2.2 Asia Non-Animal Softgel Capsules Sales by Application (2019-2030)
11.2.3 Asia Non-Animal Softgel Capsules Price by Application (2019-2030)
11.3 Asia Non-Animal Softgel Capsules Market Size by Country
11.3.1 Asia Non-Animal Softgel Capsules Revenue Grow Rate by Country (2019 VS 2023 VS 2030)
11.3.2 Asia Non-Animal Softgel Capsules Sales by Country (2019 VS 2023 VS 2030)
11.3.3 Asia Non-Animal Softgel Capsules Price by Country (2019-2030)
11.3.4 Japan
11.3.5 South Korea
11.3.6 India
11.3.7 Australia
11.3.8 China Taiwan
11.3.9 Southeast Asia
12 Middle East, Africa and Latin America
12.1 MEALA Non-Animal Softgel Capsules Market Size by Type
12.1.1 MEALA Non-Animal Softgel Capsules Revenue by Type (2019-2030)
12.1.2 MEALA Non-Animal Softgel Capsules Sales by Type (2019-2030)
12.1.3 MEALA Non-Animal Softgel Capsules Price by Type (2019-2030)
12.2 MEALA Non-Animal Softgel Capsules Market Size by Application
12.2.1 MEALA Non-Animal Softgel Capsules Revenue by Application (2019-2030)
12.2.2 MEALA Non-Animal Softgel Capsules Sales by Application (2019-2030)
12.2.3 MEALA Non-Animal Softgel Capsules Price by Application (2019-2030)
12.3 MEALA Non-Animal Softgel Capsules Market Size by Country
12.3.1 MEALA Non-Animal Softgel Capsules Revenue Grow Rate by Country (2019 VS 2023 VS 2030)
12.3.2 MEALA Non-Animal Softgel Capsules Sales by Country (2019 VS 2023 VS 2030)
12.3.3 MEALA Non-Animal Softgel Capsules Price by Country (2019-2030)
12.3.4 Mexico
12.3.5 Brazil
12.3.6 Israel
12.3.7 Argentina
12.3.8 Colombia
12.3.9 Turkey
12.3.10 Saudi Arabia
12.3.11 UAE
13 Value Chain and Sales Channels Analysis
13.1 Non-Animal Softgel Capsules Value Chain Analysis
13.1.1 Non-Animal Softgel Capsules Key Raw Materials
13.1.2 Raw Materials Key Suppliers
13.1.3 Manufacturing Cost Structure
13.1.4 Non-Animal Softgel Capsules Production Mode & Process
13.2 Non-Animal Softgel Capsules Sales Channels Analysis
13.2.1 Direct Comparison with Distribution Share
13.2.2 Non-Animal Softgel Capsules Distributors
13.2.3 Non-Animal Softgel Capsules Customers
14 Concluding Insights
15 Appendix
15.1 Reasons for Doing This Study
15.2 Research Methodology
15.3 Research Process
15.4 Authors List of This Report
15.5 Data Source
15.5.1 Secondary Sources
15.5.2 Primary Sources
15.6 Disclaimer

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings